IRIS
INSERRA, Gaetano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.299
EU - Europa 1.852
AS - Asia 1.720
SA - Sud America 375
AF - Africa 212
OC - Oceania 6
Totale 7.464
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.205
SG - Singapore 894
RU - Federazione Russa 647
CN - Cina 427
IT - Italia 374
BR - Brasile 320
IE - Irlanda 268
DE - Germania 167
VN - Vietnam 166
UA - Ucraina 130
CI - Costa d'Avorio 102
FR - Francia 94
CA - Canada 82
IN - India 50
GB - Regno Unito 48
KR - Corea 45
SN - Senegal 36
NG - Nigeria 33
SE - Svezia 29
BD - Bangladesh 26
AR - Argentina 25
IQ - Iraq 18
ZA - Sudafrica 16
HK - Hong Kong 12
PL - Polonia 12
ID - Indonesia 11
JP - Giappone 11
ES - Italia 10
FI - Finlandia 10
NL - Olanda 10
TR - Turchia 10
AT - Austria 9
EC - Ecuador 9
CH - Svizzera 8
MX - Messico 8
PK - Pakistan 8
UZ - Uzbekistan 8
CO - Colombia 7
BE - Belgio 6
MA - Marocco 6
AL - Albania 5
AU - Australia 5
ET - Etiopia 5
GR - Grecia 5
KE - Kenya 5
PY - Paraguay 5
BA - Bosnia-Erzegovina 4
LT - Lituania 4
NP - Nepal 4
SA - Arabia Saudita 4
IL - Israele 3
IR - Iran 3
LB - Libano 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CY - Cipro 2
CZ - Repubblica Ceca 2
JM - Giamaica 2
JO - Giordania 2
MY - Malesia 2
PE - Perù 2
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
MZ - Mozambico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SL - Sierra Leone 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 7.464
Salva come PNG Salva come JPEG
Città #
Singapore 518
Santa Clara 455
Dallas 429
Chandler 374
Moscow 296
Dublin 268
San Jose 169
Houston 160
Ashburn 152
Jacksonville 146
Chicago 140
Abidjan 102
Boardman 100
Beijing 99
Bremen 76
Lawrence 76
Cambridge 75
Andover 74
Nanjing 67
Lauterbourg 66
Los Angeles 54
Toronto 52
Catania 50
Des Moines 47
Seoul 45
Grafing 43
Ho Chi Minh City 43
Civitanova Marche 42
Hanoi 37
Dakar 36
Council Bluffs 35
Wilmington 35
São Paulo 27
Nanchang 26
New York 23
Saint Petersburg 21
Buffalo 20
San Mateo 19
Shenyang 19
Frankfurt am Main 17
Civitavecchia 16
The Dalles 16
Abuja 14
Hebei 14
Hefei 14
Kochi 14
Columbus 13
Lagos 13
Ottawa 13
Vicenza 13
Jiaxing 12
Orem 12
Hong Kong 11
Montreal 11
Tianjin 11
Tokyo 11
Warsaw 11
Ann Arbor 10
Changsha 10
Atlanta 9
Brasília 9
Dong Ket 9
Johannesburg 9
Manchester 8
Phoenix 8
Poplar 8
Rome 8
Helsinki 7
Milan 7
Munich 7
Pune 7
Rio de Janeiro 7
San Giuliano Milanese 7
Seattle 7
Baghdad 6
Belo Horizonte 6
Brussels 6
Curitiba 6
Modena 6
Padova 6
Port Harcourt 6
Aci Catena 5
Brooklyn 5
Chennai 5
Guangzhou 5
Guarulhos 5
Jinan 5
London 5
Messina 5
Miami 5
New Delhi 5
Palermo 5
Porto Alegre 5
Shanghai 5
Tirana 5
Amsterdam 4
Asunción 4
Bắc Ninh 4
Campinas 4
Cape Town 4
Totale 5.021
Salva come PNG Salva come JPEG
Nome #
ASSOCIATION OF IRRITABLE BOWEL SYNDROME WITH NON-EROSIVE REFLUX DISEASE 317
Anxiety, depression, chronic inflammation and aortic stiffness in Crohn’s disease: the brain-gut-vascular axis 189
PREVALENCE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS WITH CELIAC DISEASE IN EASTERN SICILY AREA 182
Arterial stiffness is increased in patients with inflammatory bowel disease 173
Can Conventional and Diffusion-Weighted MR Enterography Biomarkers Differentiate Inflammatory from Fibrotic Strictures in Crohn's Disease? 171
La Fenoverina nel trattamento della sindrome del colon irritabile 166
CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS (CMV) INFECTION IN INFLAMMATORY BOWEL DISEASE 143
Aortic Stiffness in Patients With Inflammatory Bowel Disease Reduced After Anti-Tumor Necrosis Factor Therapy 142
Crohn's disease during pregnancy 141
A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients with Crohn's Disease: Real-Life Data from the Sicilian Network for Inflammatory Bowel Disease 136
Gastrointestinal complications after kidney transplantation 133
Alterazioni carotidee in corso di insufficienza renale cronica 132
685 Risk Factor Analysis for Therapy Related Adverse Events and Infections in Elder Patients With Inflammatory Bowel Disease; An Analysis From the iG-IBD Aged Study 131
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 130
Irritable Bowel syndrome: subgroups and relationship with gastroesophageal reflux disease 125
A case of osseous metaplasia in the stomach 124
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis 123
AORTIC-BRACHIAL STIFFNESS MISMATCH STARTS EARLY IN PATIENTS WITH CHRONIC KIDNEY DISEASE 123
Overlapping of gastroesophageal reflux disease and irritable Bowel syndrome 122
Caso clinico: Una rettorragia in un giovane ragazzo 122
Uso della mesalazina e del beclometasone dipropionato nella pancolite ulcerosa. Descrizione di un caso clinico 119
Arterial structure and function in inflammatory bowel disease. 119
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions 118
RISK FACTORS OF COLORECTAL POLYPS IN MALE POPULATION OF SOUTH-EASTERN SICILY 118
Pulse wave velocity differs between ulcerative colitis and chronic kidney disease 117
Arterial stiffness in inflammatory bowel disease: a systematic review and meta-analysis 115
Colorectal Endoscopic Polipectomy: A Retrospective Study 113
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis 108
Valutazione non invasiva dei baroriflessi e della funzione carotidea nell'insufficienza renale: il sistema echotracking 106
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study” 106
Arterial stiffness in patients with inflammatory bowel diseases 105
Arterial stiffness is increased in inflammatory bowel disease, dependent upon inflammation and reduced by immunomodulatory drugs 103
EVALUATION OF CROHN'S DISEASE ACTIVITY BY DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING (MRI) 102
Clinical significance of cytomegalovirus (CMV) infection in inflammatory bowel disease 100
Letter: SPOSIB SB2—a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2 100
Linfoma non-Hodgkin ad esordio digiunale (stadio II E 2). Follow-up a medio termine di un caso trattato con chirurgia e terapia sistemica 96
PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE INCREASED ARTERIAL STIFFNESS 92
Protection By Copper (Cu++) Against Ethanol-Induced Gastric Mucosal Injury In The Rat 88
Combined use of ultrasound and GFR predictive equations for the estimation of renal function in elderly patients 87
A REAL LIFE COMPARISON OF THE EFFECTIVENESS OF ADALIMUMAB VERSUS GOLIMUMAB IN MODERATE-TO-SEVERE ULCERATIVE COLITIS. A MULTICENTRE EXPERIENCE FROM A REGIONAL NETWORK FOR INFLAMMATORY BOWEL DISEASE 87
Pepsinogen A, Pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics 84
Su1339 Ulcerative Colitis (UC) Diagnosed Over Age 65 Years -An IG-IBD Study 83
Phenotypic variation of Helicobacter pylori isolates from geographically distinct regions detected by lectin typing 82
A propensity score-matched comparison of infliximab and adalimumab in naïve and non-naïve patients with Crohn’s disease 82
LEWIS ANTIGEN EXPRESSION AND OTHER PATHOGENIC FACTORS IN THE PRESENCE OF ATROPHIC CHRONIC GASTRITIS IN A EUROPEAN POPULATION 81
Inflammation and aortic stiffness: An individual participant data meta-analysis in patients with inflammatory bowel disease 81
La clebopride nel trattamento della dispepsia funzionale: studio clinico in doppio cieco v/s placebo 81
Prevalenza di HHV6 nelle malattie infiammatorie dell’intestino 79
Hiatal Hernia And Reflux Esophagitis: An Endoscopic Study 78
Crohn's disease of the small bowel: evaluation of ileal inflammation by diffusion-weighted MR imaging and correlation with the Harvey-Bradshaw index 76
PREVALENZA DI HHV6 NELLE MALATTIE INFIAMMATORIE DELL’INTESTINO 76
Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study 75
Subclinical atherosclerosis in patients with inflammatory bowel diseases: A systematic review and meta-analysis 74
Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine. A single-blind randomized controlled trial 73
Increased cardiovascular risk in subjects with a low prevalence of classic cardiovascular risk factors: The inflammatory bowel disease paradox 73
P181 Diagnostic performance of Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) in the evaluation of stenosis and endoscopic recurrence in Crohn's disease 70
Inflammation and Aortic Pulse Wave Velocity: A Multicenter Longitudinal Study in Patients With Inflammatory Bowel Disease 70
COMPARISON OF ESTIMATING GFR FORMULAS IN ELDERLY 69
Inflammatory bowel diseases and pericarditis 68
OC.02.4 THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD): A COMPARISON OF THE EFFICACY OF CURRENT BIOLOGICS IN CROHN'S DISEASE 68
Estimated GFR and renal sinus section area are independent predictors of renal dysfunction in elderly 67
Omeprazole vs. ranitidine in short-term treatment of Helicobacter pylori positive duodenal ulcer patients 65
Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 64
Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs 61
P737 SPOSIB SB2: A Sicilian prospective observational study of patients with inflammatory bowel disease treated with infliximab Biosimilar SB2 (Flixabi®): interim analysis 61
P.05.22 INFLAMMATORY BOWEL DISEASES AND PERICARDITIS 60
P.07.1 ELDERLY PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) ARE LESS LIKELY TO PERSIST ON ANTI-TNF THERAPY COMPARED WITH YOUNGER PATIENTS. DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASES (SN-IBD) 60
Patient and physician views on the quality of care for inflammatory bowel disease after one-year follow-up: Results from SOLUTION-2, a prospective IG-IBD study 59
P.05.4 ARTERIAL STIFFNESS IS INCREASED IN IBD PATIENTS 58
Patient and physician views on the quality of care in inflammatory bowel disease: Results from SOLUTION-1, a prospective IG-IBD study 58
P539 Does a change in therapeutic approach modify outcome in IBD patients? A comparison between two cohorts 2004–2007 and 2010–2013 57
OC.12.3 SPOSIB SB2 – A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2 (FLIXABI®): INTERIM ANALYSIS 56
Early anti-tumor necrosis factor therapy reduces aortic stiffness in inflammatory bowel disease: a multicentre longitudinal study 56
OC.06.2: The Sicilian Network of Biological Therapy in Inflammatory Bowel Disease: Preliminary Data from a Prospective Study on Efficacy and Safety 54
P545 Elderly patients with inflammatory bowel disease (IBD) are less likely to persist on anti-TNF therapy compared with younger patients: data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 53
Estimation of cardiovascular risk according to asymptomatic organ damage in subjects with inflammatory bowel disease 53
P412 The Sicilian network of biological therapy in inflammatory bowel disease: preliminary data on efficacy 51
Totale 7.640
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.356
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.356
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202170 0 0 0 0 0 0 0 0 0 17 33 20
2021/2022535 64 80 4 15 85 5 80 18 34 1 16 133
2022/20231.037 85 67 25 170 81 171 4 175 223 5 25 6
2023/2024366 23 57 21 12 16 66 19 28 3 7 83 31
2024/20251.613 20 231 97 79 351 215 65 64 144 137 114 96
2025/20262.931 183 78 495 239 486 691 360 59 219 121 0 0
Totale 7.640